X0202 SCHEDULE 13G/A 0002049841 XXXXXXXX LIVE 1 Common Shares, no par value per share 03/31/2026 0001997296 Medicus Pharma Ltd. 58471K202 100 KING STREET WEST SUITE 3400 ONTARIO A6 M5X 1A4 Rule 13d-1(d) Raju Ajay b X1 2031250.00 0.00 2031250.00 0.00 2031250.00 N 3.7 IN (1) Consists of 2,000,000 common shares (the "Common Shares") of Medicus Pharma Ltd. (the "Company") held of record by 215 Capital Togo PHL Fund I, LP ("215 Capital") and 31,250 Common Shares underlying stock options held of record by Mr. Ajay Raju that are currently exercisable. Togo PHL Management LLC (the "Management Company") has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein. (2) Based on 55,164,465 Common Shares outstanding as of April 30, 2026 as reported in the Company's Definitive Proxy Statement on Schedule 14A filed on May 4, 2026. 215 Capital Togo PHL Fund I, LP b DE 2000000.00 0.00 2000000.00 0.00 2000000.00 N 3.6 PN (1) Consists of 2,000,000 the Common Shares of the Company held of record by 215 Capital. The Management Company has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein. (2) Based on 55,164,465 Common Shares outstanding as of April 30, 2026 as reported in the Company's Definitive Proxy Statement on Schedule 14A filed on May 4, 2026. Togo PHL Management LLC b DE 2000000.00 0.00 2000000.00 0.00 2000000.00 N 3.6 OO (1) Consists of 2,000,000 the Common Shares of the Company held of record by 215 Capital. The Management Company has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein. (2) Based on 55,164,465 Common Shares outstanding as of April 30, 2026 as reported in the Company's Definitive Proxy Statement on Schedule 14A filed on May 4, 2026. Medicus Pharma Ltd. 300 Conshohocken State Road, Suite 200, W. Conshohocken, PA 19428 i. Ajay Raju ii. Togo PHL Management LLC; iii. 215 Capital Togo PHL Fund I, LP; Two Liberty Place 50 South 16th Street Suite 2710 Philadelphia, Pennsylvania 19102 i. Ajay Raju (United States) ii. Togo PHL Management LLC (Delaware) iii. 215 Capital Togo PHL Fund I, LP (Delaware) Y The information contained in Items 5-9 of the cover pages of this amended Schedule 13G is hereby incorporated by reference into this Item 4. 3.7 2,031,250 0 2,031,250 0 N Y Y Y Y Y Y Exhibit 99.1 Joint Filing Agreement was previously filed: https://www.sec.gov/Archives/edgar/data/1997296/000121465925000501/ex99_1.htm. Raju Ajay /s/ Ajay Raju 05/04/2026 215 Capital Togo PHL Fund I, LP /s/ Ajay Raju 05/04/2026 Togo PHL Management LLC /s/ Ajay Raju 05/04/2026